RxDoctor Payments Data

Celeste Angel, DO

Dermatology · Leawood, KSNPI 1568669794

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 302 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,763 and has fallen 89.5% since, to $184 in 2025.

$5,933in general payments, 2019–2025

Across 302 payments — averaging $19.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Sun Pharmaceutical Industries Inc.$575
  • E.r. Squibb & Sons, L.L.C.$427
  • Novartis$420
  • Johnson & Johnson$322
  • Lilly USA, LLC$299
  • plus $3K from 29 others

What the payments were for

  • Food & beverage$5,90399%
  • Education$301%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,933 in reported general payments places this provider in the 80th percentile of 82 dermatology providers in Kansas.

See all dermatology providers in Kansas

Medicare billing

Part B allowed, 2024
$62,739
Medicare patients
360
Services billed
955

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate37$2,417
Doxycycline Hyclate49$1,980
Metronidazole29$1,869
Ketoconazole70$1,546
Ciclopirox34$1,109
ValacyclovirValacyclovir Hcl18$417
Triamcinolone Acetonide43$334

Paid to pharmacies, not to this prescriber.

Other dermatology in Leawood

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →